| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8836698 | Surgery | 2018 | 7 Pages |
Abstract
TJ-14 reduced the incidence of reflux-induced esophageal cancer and the infiltration of M2 macrophages in a surgical rat model or suppressed prostaglandin E2 production in esophageal squamous cell carcinoma cell. Further investigation is required regarding the potential clinical use of TJ-14 as an esophageal cancer chemopreventive agent.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Tomoharu MD, PhD, Toru MD, PhD, FACS, Daisuke MD, PhD, Yuki MD, PhD, Daichi MD, PhD, Naoki MD, PhD, Shinichi MD, PhD, Koichi MD, PhD, Isamu MD, PhD, Jun MD, PhD, Keishi MD, PhD, Katsunobu MD, PhD, Hidehiro MD, PhD, Hiroyuki MD, PhD, Itasu MD, PhD,